» Articles » PMID: 28401107

Is N-acetylcysteine Infusion an Effective Treatment Option in L-asparaginase Associated Hepatotoxicity?

Overview
Journal Blood Res
Publisher Springer Nature
Specialty Hematology
Date 2017 Apr 13
PMID 28401107
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

TY-S01 protects against alcoholic liver injury in mice by regulating intestinal barrier function and gut microbiota.

Shu X, Wang J, Zhao L, Wang J, Wang P, Zhang F Heliyon. 2023; 9(7):e17878.

PMID: 37539263 PMC: 10395298. DOI: 10.1016/j.heliyon.2023.e17878.


Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature.

Schulte R, Madiwale M, Flower A, Hochberg J, Burke M, McNeer J Leuk Lymphoma. 2018; 59(10):2360-2368.

PMID: 29431566 PMC: 10183102. DOI: 10.1080/10428194.2018.1435873.

References
1.
Baumgardner J, Shankar K, Hennings L, Albano E, Badger T, Ronis M . N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. J Nutr. 2008; 138(10):1872-9. PMC: 2935161. DOI: 10.1093/jn/138.10.1872. View

2.
Jaeschke H, Gores G, Cederbaum A, Hinson J, Pessayre D, Lemasters J . Mechanisms of hepatotoxicity. Toxicol Sci. 2002; 65(2):166-76. DOI: 10.1093/toxsci/65.2.166. View

3.
Alshiekh-Nasany R, Douer D . L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity. Acta Haematol. 2016; 135(4):208-10. DOI: 10.1159/000442342. View

4.
Al-Nawakil C, Willems L, Mauprivez C, Laffy B, Benmrad M, Tamburini J . Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors. Leuk Lymphoma. 2013; 55(7):1670-4. DOI: 10.3109/10428194.2013.845886. View

5.
Clavell L, Gelber R, Cohen H, Cassady J, Tarbell N, Blattner S . Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med. 1986; 315(11):657-63. DOI: 10.1056/NEJM198609113151101. View